That’s ok. Virtis to me is a non-event, and essentially simply a bonus to the baseline spinal stim product.
To the market it different, because the larger market truly has no comprehension of the Stim market in specific. Do you understand how SMALL a niche Sacral Stim is?? It is relatively nothing.
So I’m quite content with the rest of the market not understanding the only real value in Nuvectra is in the strength of its SCS system; which is second in capability only to Boston’s Wavewriter.
I added 10k shares thus far today. Bring it lower!
Buyout alone for the TECH, will net 500 mil to 1B.
Just do the math, ignore the market noise, and buy.
But trust your own DD. Not mine. I only implant these devices every day....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.